A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
Clinical trial NCT04586010 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04586010
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-17
- Primary completion
- 2026-01-27
- Enrollment
- 746
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.